Vimovo and Sensipar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimovo (esomeprazole magnesium; naproxen) and Sensipar (cinacalcet hydrochloride). Common drug interactions include cardiac arrest among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Vimovo and Sensipar. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.

What is Sensipar?

Sensipar has active ingredients of cinacalcet hydrochloride. It is often used in hyperparathyroidism secondary. eHealthMe is studying from 46,034 Sensipar users. Check the latest studies of Sensipar.



On Jul, 07, 2026

18 people who take Vimovo and Sensipar together, and have interactions are studied.

Vimovo and Sensipar drug interactions.

What are the common drug interactions of Vimovo and Sensipar, by gender? *:

female:

  1. Cardiac arrest
  2. Cardiovascular disorder (heart diseases)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  5. Hypertensive heart disease
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Renal disorder (kidney disease)
  8. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  9. Renal failure (kidney dysfunction)
  10. Chronic kidney disease

male:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)

What are the common drug interactions of Vimovo and Sensipar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Hypertensive heart disease
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Renal disorder (kidney disease)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Death
  10. Sudden cardiac death

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 66.67%
  2. High Blood Pressure: 9 people, 50.00%
  3. High Blood Cholesterol: 6 people, 33.33%
  4. Stress And Anxiety: 3 people, 16.67%
  5. Pain: 3 people, 16.67%
  6. Indigestion: 3 people, 16.67%
  7. Dyspnea (difficult or laboured breathing): 3 people, 16.67%
  8. Diabetes: 3 people, 16.67%
  9. Oedema (fluid collection in tissue): 2 people, 11.11%
  10. Gout (uric acid crystals building up in the body): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Vimovo and Sensipar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vimovo and Sensipar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sensipar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sensipar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium; naproxen and cinacalcet hydrochloride (the active ingredients of Vimovo and Sensipar, respectively), and Vimovo and Sensipar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: